Chinese Hamster Ovary Consortium (CHOC)

Download Profile PDF
At a Glance
  • Status: Completed Consortium
  • Year Launched: 2006
  • Initiating Organization: Society for Biological Engineering
  • Initiator Type: Academia
  • No disease focus
  • Location: International

Abstract

The Society for Biological Engineering established the Chinese Hamster Ovary (CHO) Consortium to build on earlier work that successfully completed the sequencing and annotation of the Chinese hamster genome.

Mission

The CHO consortium objectives include further characterize the Chinese hamster and CHO cell genomes, develop tools to assess CHO production cell line stability, develop the tools for ultimately manipulating glycosylation patterns in order to enhance product quality, and develop CHO transcriptome analysis tools.

Structure & Governance

Consortium members pool their resources to support the ongoing work. Each member company designates a representative to the Project Management Committee and helps guide upcoming research.  The research will facilitate the use of genomics in enhancing the robustness, manufacturing, and quality of biotherapeutics.

Homepage

http://www.aiche.org/sbe/community/cho-consortium

Sponsors & Partners

Bioprocessing Technology Institute at the Agency for Science, Technology, and Research in Singapore

Boehringer Ingelheim

Bristol-Myers Squibb

SAFC Biosciences

Schering Plough

Society for Biological Engineering

University of Minnesota

Last Updated: 04/14/2016
The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.
Register your consortium  
All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.